Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **human beta-globin gene** encodes the **beta-globin** protein, a critical component of adult hemoglobin found in red blood cells. Hemoglobin is a tetramer composed of two alpha and two beta chains; each chain binds heme to facilitate oxygen transport from lungs to tissues throughout the body. The human β-globin locus on chromosome 11 contains several related genes expressed at different developmental stages. Mutations in this gene cause major inherited disorders such as sickle cell disease—where abnormal hemoglobin S leads to misshapen red cells—and various forms of **beta-thalassemia**, which result from reduced or absent production of functional β-globin chains. Modified versions of the human β-globin gene are being developed for therapeutic purposes using techniques like lentiviral-mediated addition or CRISPR-based correction to restore normal function in patients with these diseases[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human beta-globin gene (HBB).